1. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Issue 5 (2nd January 2014) Authors: Das, Sudipto; Vital, Edward M; Horton, Sarah; Bryer, Domini; El-Sherbiny, Yasser; Rawstron, Andrew C; Ponchel, Frederique; Emery, Paul; Buch, Maya H Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 5(2014) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗